2 Exceptional Growth Stocks to Buy for Under $100
https://www.fool.com/investing/2024/06/27/2-exceptional-growth-stocks-to-buy-for-under-100/?source=iedfolrf0000001
Jun 27, 2024 - These beaten-down stocks may be overlooked by some investors, but that could be a golden opportunity for others.
0
Novavax (NVAX) Seeks Nod for Updated COVID-19 Jab in Europe
https://www.zacks.com/stock/news/2293102/novavax-nvax-seeks-nod-for-updated-covid-19-jab-in-europe?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2293102
Jun 25, 2024 - Novavax (NVAX) seeks marketing authorization in the European Union for an updated version of its COVID-19 vaccine, which has been formulated to target the JN.1 variant.
0
Pfizer's Working on the Next Wegovy, but Can It Beat Novo Nordisk?
https://www.fool.com/investing/2024/06/25/pfizers-working-on-the-next-wegovy-but-can-it-beat/?source=iedfolrf0000001
Jun 25, 2024 - This is a matchup that the latecomer might not be able to win.
0
5 Dividend Stocks Yielding at Least 5% to Buy Right Now for Passive Income
https://www.fool.com/investing/2024/06/25/5-dividend-stocks-yielding-at-least-5-to-buy-right/?source=iedfolrf0000001
Jun 25, 2024 - These companies pay well above average dividends.
0
3 No-Brainer Stocks to Buy for Under $100 Right Now
https://www.fool.com/investing/2024/06/22/3-no-brainer-stocks-to-buy-for-under-100-right-now/?source=iedfolrf0000001
Jun 22, 2024 - You won't need much money to start investing in these great stocks.
0
FDA Expands Sarepta's (SRPT) DMD Gene Therapy Label
https://www.zacks.com/stock/news/2291689/fda-expands-sarepta-s-srpt-dmd-gene-therapy-label?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2291689
Jun 21, 2024 - Following the label expansion, Sarepta's (SRPT) Elevidys is approved to treat all DMD patients aged four years and older, regardless of ambulation status.
0
Here's Why Eli Lilly (LLY) is Probably the Best Drug Stock Now
https://www.zacks.com/stock/news/2290782/here-s-why-eli-lilly-lly-is-probably-the-best-drug-stock-now?cid=CS-ZC-FT-analyst_blog|most_popular_stocks-2290782
Jun 20, 2024 - Eli Lilly (LLY) enjoys strong fundamentals and is expected to consistently do well, mainly supported by its new drugs and its solid pipeline.
0
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
https://www.zacks.com/stock/news/2289405/novavax-nvax-seeks-fda-nod-for-updated-covid-19-vaccine?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2289405
Jun 17, 2024 - Novavax (NVAX) seeks FDA???s approval to update its COVID-19 vaccine for the 2024-2025 fall season against current circulating strains, including KP.2 and KP.3.
0
3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a Decade
https://www.fool.com/investing/2024/06/15/3-high-yield-sp-500-dividend-stocks-down-more-than/?source=iedfolrf0000001
Jun 15, 2024 - Their prices might not be done falling, but you can count on the dividends they distribute to continue rising steadily.
0
Is It Too Late to Buy Pfizer Stock?
https://www.fool.com/investing/2024/06/14/is-it-too-late-to-buy-pfizer-stock/?source=iedfolrf0000001
Jun 14, 2024 - It's no secret that the last year has been punishing.
0